24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
Corporate
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Medtech
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
Corporate
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
14:27
Cisco posts its fastest growth in 15 years with about 8,000 fewer employees than two years ago
14:02
Colette Kress helped bring Israel to the heart of Nvidia's AI business. Now she's in charge.
13:49
Microsoft outage drags into a second day, disrupting businesses and governments worldwide
10:43
When teams can build faster than they can agree
More stories
Buzz
Most popular
Daily
Weekly
1
“The next Palo Alto Networks has already been born, and it is probably in Tel Aviv”
2
CrowdStrike's business chief: "We're long on Israel and we're not going anywhere"
3
The race to replace Jensen Huang: Nvidia's potential successors include an Israeli executive
4
Palo Alto’s $25 billion CyberArk deal was worth $21 billion at closing. The shares are now worth $37 billion
5
CyberArk layoffs cost Palo Alto an estimated $60 million
More news
Medtech
20 stories about Medtech
After raising $100 million, Israeli medical device maker Art Medical turns to court for help
10.11.26
|
Lital Dobrovitzky
The company received backing from the Bill & Melinda Gates Foundation and the Israel Innovation Authority, but an FDA regulatory setback has left it without the financing needed to continue operating. It is asking the court to appoint a temporary trustee and explore a possible sale.
"You cannot conquer the whole continent in one move"
03.11.26
|
Amy Shapiro
NeuroKaire Head of Commercial David Sachs explains the intricacies of entering the US market as a healthcare startup, and the importance of not treating a foreign market as a monolith.
"We're the first hospital outside the US that gets the latest capabilities of OpenAI"
01.11.26
|
Amy Shapiro
Sheba Impact CEO and ARC Director Avner Halperin details the hospital's ambitions to implement artificial intelligence across all wards by 2027.
UltraSight raises $24 million to tackle shortage of cardiac imaging specialists
23.09.26
|
Sophie Shulman
The Israeli startup’s AI platform enables trained medical staff to perform echocardiograms and is already installed in intensive care units at more than 10 medical facilities.
Israeli medtech company FIZE Medical raises $20 million to advance AI-guided ICU care
17.09.26
|
Sophie Shulman
The Series B, co-led by Asahi Kasei Medical and Rapha Capital, will accelerate development of a platform designed to predict fluid-related risks in critically ill patients.
The Israel Innovation Authority is spearheading a $23.3M investment to establish an AI consortium for personalized medicine
12.07.26
|
Meir Orbach
The Israel Innovation Authority, NVIDIA, and several more companies and universities will establish a consortium to develop the next generation of AI applications in biology, drug discovery, and personalized medicine.
Salignostics receives $1.87 million Gates Foundation grant for saliva-based HIV and pregnancy tests
03.06.26
|
CTech
Funding to accelerate non-invasive diagnostics aimed at improving access in developing regions.
Olympus to buy Israel’s BioProtect for $270 million in cash
26.05.26
|
Meir Orbach
Japanese medtech group expands into prostate cancer treatment devices with all-cash deal.
Artivion to acquire Israeli medtech firm Endospan in deal worth up to $335 million
18.05.26
|
Meir Orbach
FDA approval for Endospan’s aortic repair system triggers long-awaited acquisition option.
“We're too slow in the adoption of AI technologies in healthcare”
05.05.26
|
Zachy Hennessey
Sheba Impact CEO Avner Halperin explains why AI is becoming central to telehealth, from triage and intake to expanding access to care while keeping clinicians in the loop.
Medtronic to lay off 60 employees at Jerusalem R&D center
27.10.25
|
Maayan Cohen Rozen
U.S. medical device giant moves to streamline operations as part of a global realignment.
The startup that wants to redefine stage four cancer
23.10.25
|
Hagai Gilboa, Maor Shalom Swisa
By heating tumors at the cellular level, New Phase hopes to transform treatment outcomes.
Aidoc receives Breakthrough Device Designation from FDA for multi-triage imaging AI
30.09.25
|
CTech
“The new technology means our mission is at hand - to support physicians in every patient encounter,” said Elad Walach, Co-Founder and CEO.
Escala Medical raises $4.5M Series A for safer pelvic prolapse treatment
21.07.25
|
Amy Shapiro
Co-financed by the EIC Fund, the raise will support global expansion of Escala’s FDA-approved women’s health solution for pelvic organ prolapse.
Restore Medical secures $23M Series B to push forward novel heart failure therapy
07.07.25
|
CTech
The new funding will allow the Israeli startup to complete an ongoing feasibility study in Europe, where early results have shown what the company describes as encouraging long-term safety and efficacy data.
ForSight Robotics raises $125M Series B to advance AI-powered eye surgery system
24.06.25
|
Meir Orbach
Israeli medtech firm’s ORYOM platform aims to expand access to precision eye care globally.
NimBio unveils AI-powered Inflammometer to predict IBD flares before they strike
09.06.25
|
CTech
The company has raised a total of $2 million for its non-invasive technology, helping those with Inflammatory Bowel Diseases.
Canopy appoints Avi Revivo as CTO and GM Israel
04.06.25
|
CTech
“His joining will help us realize the full potential of AI in oncology, significantly increase the value we provide to our clients, and create real impact in patients’ lives,” said Founder and CEO Lavi Kwiatkowsky.
Somite AI secures $47.5 million Series A to expand AI platform for cell therapy
13.05.25
|
James Spiro
The company is developing DeltaStem, an AI-driven platform designed to improve the production of human cells for therapeutic use.
How combat medicine accelerates innovation and reshapes global healthcare
29.04.25
|
Avner Halperin
"We must ensure that the medical inventions arising from today’s combat realities evolve into tangible healthcare products that save lives - not only on the battlefield but also on highways, in trauma centers, and operating rooms worldwide," writes Avner Halperin, CEO of Sheba Impact and the ARC Innovation Center at Sheba Medical Center.
More Articles